Latest News
August 08, 2022
Not intended for U.S. and UK Media
U.S. FDA approves additional indication of darolutamide in combination with docetaxel for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC)
August 04, 2022
Second quarter of 2022
Bayer: Strong growth, outlook raised
July 14, 2022
Not intended for U.S. and UK Media
Bayer to sell men’s health product Nebido™ to Grünenthal

Find Your Product

With our products we contribute to the health of people and plants. Here you find an overview of the major Bayer products.